152 related articles for article (PubMed ID: 7180192)
1. [Basis for prescribing bradykinin antagonists in neurodermatitis and data on the therapeutic effectiveness of parmidin in this dermatosis].
Grebennikov VA
Vestn Dermatol Venerol; 1982 Sep; (9):46-9. PubMed ID: 7180192
[No Abstract] [Full Text] [Related]
2. [Pathogenetic treatment of patients with disseminated neurodermatitis using the specific antikinin preparation parmidin].
Grebennikov VA
Sov Med; 1983; (1):44-7. PubMed ID: 6836389
[No Abstract] [Full Text] [Related]
3. [Antagonism of parmidin to kinin effects].
Shvarts GIa; Faermark IF; Siubaev RD
Farmakol Toksikol; 1985; 48(6):37-41. PubMed ID: 4085627
[TBL] [Abstract][Full Text] [Related]
4. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
Solov'eva IP; Makinskiĭ AI
Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
[No Abstract] [Full Text] [Related]
5. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
Matiashina GI
Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
[TBL] [Abstract][Full Text] [Related]
6. [Growth and metastasis of Lewis' lung carcinoma in mice under the pharmacological action on metabolism and the effects of kinins].
Veksler IG; Riabukha VN; Chubinskaia SG; Shvarts GIa
Biull Eksp Biol Med; 1987 Jul; 104(7):79-81. PubMed ID: 3620655
[TBL] [Abstract][Full Text] [Related]
7. [Effect of parmidine and drugs affecting kinin metabolism on pain reactions in mice].
Shvarts GIa
Farmakol Toksikol; 1981; 44(5):606-11. PubMed ID: 7308443
[No Abstract] [Full Text] [Related]
8. [Effect of pyridinolcarbamate (parmidine) on some bradykinin effects].
Shvarts GIa; Mashkovskiĭ MD
Farmakol Toksikol; 1976; 39(2):176-9. PubMed ID: 1278349
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
[No Abstract] [Full Text] [Related]
10. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
[No Abstract] [Full Text] [Related]
11. [Effect of prodectin on the activity of the blood kallikrein-kinin system in diffuse toxic goiter].
Oleĭnik VA; Matiashina GI
Probl Endokrinol (Mosk); 1986; 32(4):7-10. PubMed ID: 3639497
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of action and clinical effectiveness of the new Soviet-made drug parmidin in the treatment of arteriosclerosis and ischemic heart disease].
Kukes VG; Mashkovskiĭ MD; Paskhina TS; Borisov VG; Shvarts GIa
Kardiologiia; 1978 Oct; 18(10):61-8. PubMed ID: 213636
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of the anti-inflammatory action of pyridinolcarbamate].
Shvarts GIa; Liberman SS; Mashkovskiĭ MD; Berliand EA
Farmakol Toksikol; 1975; 38(4):434-6. PubMed ID: 1213130
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of the antikinin preparation pyridinolcarbamate on the development of experimental tuberculosis].
Makinskiĭ AI; Solov'eva IP; Braude VI
Probl Tuberk; 1984 May; (5):60-5. PubMed ID: 6739480
[No Abstract] [Full Text] [Related]
15. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
[No Abstract] [Full Text] [Related]
16. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
Fényes G; Gótzy G; Fehrentheil L
Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
[No Abstract] [Full Text] [Related]
17. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
18. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
19. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
[No Abstract] [Full Text] [Related]
20. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
Parodi FA; Caputo G
Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
